<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="zh-TW" xml:lang="zh-TW"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.3.450">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>2024MSC - 2024 TMM Project</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "navbar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "end",
  "type": "overlay",
  "limit": 20,
  "language": {
    "search-no-results-text": "没有结果",
    "search-matching-documents-text": "匹配的文档",
    "search-copy-link-title": "复制搜索链接",
    "search-hide-matches-text": "隐藏其它匹配结果",
    "search-more-match-text": "更多匹配结果",
    "search-more-matches-text": "更多匹配结果",
    "search-clear-button-title": "清除",
    "search-detached-cancel-button-title": "取消",
    "search-submit-button-title": "提交",
    "search-label": "搜索"
  }
}</script>


<link rel="stylesheet" href="styles.css">
</head>

<body class="nav-fixed">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
    <nav class="navbar navbar-expand-lg navbar-dark ">
      <div class="navbar-container container-fluid">
      <div class="navbar-brand-container">
    <a class="navbar-brand" href="./index.html">
    <span class="navbar-title">2024MSC</span>
    </a>
  </div>
            <div id="quarto-search" class="" title="搜索"></div>
          <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarCollapse" aria-controls="navbarCollapse" aria-expanded="false" aria-label="切换导航" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
  <span class="navbar-toggler-icon"></span>
</button>
          <div class="collapse navbar-collapse" id="navbarCollapse">
            <ul class="navbar-nav navbar-nav-scroll me-auto">
  <li class="nav-item">
    <a class="nav-link" href="./index.html" rel="" target="">
 <span class="menu-text">Home</span></a>
  </li>  
  <li class="nav-item">
    <a class="nav-link" href="./agenda.html" rel="" target="">
 <span class="menu-text">Agenda</span></a>
  </li>  
  <li class="nav-item">
    <a class="nav-link" href="./abstract_uploads.html" rel="" target="">
 <span class="menu-text">Abstract and keynote</span></a>
  </li>  
  <li class="nav-item">
    <a class="nav-link" href="./2022_2024_dengue_statistics_HGH.html" rel="" target="">
 <span class="menu-text">Malaria and Dengue Co-infection</span></a>
  </li>  
  <li class="nav-item">
    <a class="nav-link" href="./2024Project_HGH_laparoscopicCentre.html" rel="" target="">
 <span class="menu-text">Laparoscopic Centre</span></a>
  </li>  
  <li class="nav-item">
    <a class="nav-link" href="./2024Project_HGH_pathology_LIMS.html" rel="" target="">
 <span class="menu-text">HGH Pathology LIMS</span></a>
  </li>  
  <li class="nav-item">
    <a class="nav-link" href="./thanks.html" rel="" target="">
 <span class="menu-text">Acknowledgements</span></a>
  </li>  
  <li class="nav-item">
    <a class="nav-link" href="./questionnaire.html" rel="" target="">
 <span class="menu-text">Questionnaire</span></a>
  </li>  
  <li class="nav-item">
    <a class="nav-link" href="./h2023MSC.html" rel="" target="">
 <span class="menu-text">2023MSC</span></a>
  </li>  
  <li class="nav-item">
    <a class="nav-link" href="./about.html" rel="" target="">
 <span class="menu-text">About TMM</span></a>
  </li>  
</ul>
            <div class="quarto-navbar-tools ms-auto">
</div>
          </div> <!-- /navcollapse -->
      </div> <!-- /container-fluid -->
    </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article page-navbar">
<!-- sidebar -->
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">该页面内容</h2>
   
  <ul>
  <li><a href="#progress-report-20240527" id="toc-progress-report-20240527" class="nav-link active" data-scroll-target="#progress-report-20240527">Progress Report (2024/05/27)</a></li>
  <li><a href="#progress-report-20240612" id="toc-progress-report-20240612" class="nav-link" data-scroll-target="#progress-report-20240612">Progress Report (2024/06/12)</a></li>
  <li><a href="#progress-report-20240628" id="toc-progress-report-20240628" class="nav-link" data-scroll-target="#progress-report-20240628">Progress Report (2024/06/28)</a></li>
  <li><a href="#progress-report-20240710" id="toc-progress-report-20240710" class="nav-link" data-scroll-target="#progress-report-20240710">Progress Report (2024/07/10)</a></li>
  <li><a href="#progress-report-20240807" id="toc-progress-report-20240807" class="nav-link" data-scroll-target="#progress-report-20240807">Progress Report (2024/08/07)</a></li>
  <li><a href="#tmm-projects-進度四大項" id="toc-tmm-projects-進度四大項" class="nav-link" data-scroll-target="#tmm-projects-進度四大項">TMM Projects 進度(四大項)</a>
  <ul class="collapse">
  <li><a href="#年登革熱追蹤管理暨加護病房重症支援" id="toc-年登革熱追蹤管理暨加護病房重症支援" class="nav-link" data-scroll-target="#年登革熱追蹤管理暨加護病房重症支援">1. 2024年登革熱追蹤管理暨加護病房重症支援</a>
  <ul class="collapse">
  <li><a href="#計劃概述" id="toc-計劃概述" class="nav-link" data-scroll-target="#計劃概述">計劃概述</a></li>
  <li><a href="#主要內容更新-20240807" id="toc-主要內容更新-20240807" class="nav-link" data-scroll-target="#主要內容更新-20240807">主要內容更新 (2024/08/07)</a></li>
  <li><a href="#action-pointswhowhen" id="toc-action-pointswhowhen" class="nav-link" data-scroll-target="#action-pointswhowhen"><strong>Action Points</strong>(who/when)</a></li>
  <li><a href="#計劃概述-archieved-20240807" id="toc-計劃概述-archieved-20240807" class="nav-link" data-scroll-target="#計劃概述-archieved-20240807">計劃概述 (archieved) (2024/08/07)</a></li>
  <li><a href="#主要內容更新" id="toc-主要內容更新" class="nav-link" data-scroll-target="#主要內容更新">主要內容更新</a></li>
  <li><a href="#action-pointswhowhen-1" id="toc-action-pointswhowhen-1" class="nav-link" data-scroll-target="#action-pointswhowhen-1"><strong>Action Points</strong>(who/when)</a></li>
  <li><a href="#醫療外交亮點" id="toc-醫療外交亮點" class="nav-link" data-scroll-target="#醫療外交亮點">醫療外交亮點</a></li>
  </ul></li>
  <li><a href="#visiting-scholarships-for-training-in-taiwan" id="toc-visiting-scholarships-for-training-in-taiwan" class="nav-link" data-scroll-target="#visiting-scholarships-for-training-in-taiwan">2. Visiting Scholarships for Training in Taiwan</a></li>
  <li><a href="#骨質健康計劃" id="toc-骨質健康計劃" class="nav-link" data-scroll-target="#骨質健康計劃">3. 骨質健康計劃</a></li>
  <li><a href="#三項癌症防治計畫子宮頸癌乳癌肝癌" id="toc-三項癌症防治計畫子宮頸癌乳癌肝癌" class="nav-link" data-scroll-target="#三項癌症防治計畫子宮頸癌乳癌肝癌">4. 三項癌症防治計畫(子宮頸癌、乳癌、肝癌)</a></li>
  </ul></li>
  </ul>
</nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title">2024 TMM Project</h1>
</div>



<div class="quarto-title-meta">

    
  
    
  </div>
  

</header>

<!--





-->
<p><img src="images/in-islamic-style-please-generate-an-illustration-t-20To_QkjSzq0xI_1XG5vAA-o803jGFyQaKUlTwVwHmazA.jpeg" alt="Progress Report (2024/05/27)" style="width: 100%; height: auto;"></p>
<section id="progress-report-20240527" class="level2">
<h2 class="anchored" data-anchor-id="progress-report-20240527">Progress Report (2024/05/27)</h2>
</section>
<section id="progress-report-20240612" class="level2">
<h2 class="anchored" data-anchor-id="progress-report-20240612">Progress Report (2024/06/12)</h2>
</section>
<section id="progress-report-20240628" class="level2">
<h2 class="anchored" data-anchor-id="progress-report-20240628">Progress Report (2024/06/28)</h2>
</section>
<section id="progress-report-20240710" class="level2">
<h2 class="anchored" data-anchor-id="progress-report-20240710">Progress Report (2024/07/10)</h2>
</section>
<section id="progress-report-20240807" class="level2">
<h2 class="anchored" data-anchor-id="progress-report-20240807">Progress Report (2024/08/07)</h2>
</section>
<section id="tmm-projects-進度四大項" class="level1">
<h1>TMM Projects 進度(四大項)</h1>
<p>*<strong>公共衛生</strong></p>
<section id="年登革熱追蹤管理暨加護病房重症支援" class="level2">
<h2 class="anchored" data-anchor-id="年登革熱追蹤管理暨加護病房重症支援">1. 2024年登革熱追蹤管理暨加護病房重症支援</h2>
<section id="計劃概述" class="level3">
<h3 class="anchored" data-anchor-id="計劃概述">計劃概述</h3>
<p>本計劃旨在支援索馬利蘭的登革熱防治工作，重點包括強化疾病監測系統、提升重症管理能力，並協助建立完善的資料收集和分析機制。鑑於目前疫情升溫，我們將優先建立HGH lab的RDT-confirmed dengue cases surveillance system，作為eIDSR的第一階段，以快速掌握疫情動態並有效利用資源。</p>
</section>
<section id="主要內容更新-20240807" class="level3">
<h3 class="anchored" data-anchor-id="主要內容更新-20240807">主要內容更新 (2024/08/07)</h3>
<ol type="1">
<li><strong>登革熱疫情監控（IDSR and eIDSR）</strong>
<ul>
<li>協助MoHD實施整合性疾病監測與應對（IDSR）系統</li>
<li>優先在HGH lab建立RDT-confirmed dengue cases surveillance system，作為eIDSR第一階段</li>
<li>後續支援eIDSR在4家公立醫院的整合：Hargeisa、Boroma、Berbera和Burco (ICDF HIS)</li>
<li>推動mHealth於區域醫院、衛生中心和社區的應用</li>
<li>確保臺灣供應的RDT能透過新建立的stage I eIDSR系統有效追蹤使用情況</li>
</ul></li>
<li><strong>加護病房重症支援</strong>
<ul>
<li>提供動脈血液氣體分析試劑，用於加護病房重症患者</li>
<li>協助引進高品質登革熱NS1快速診斷測試（RDT），避免價廉品質不佳的產品</li>
<li>支援HGH實驗室進行IgM/IgG抗體ELISA檢測</li>
<li>由李枝新主任主導呼吸器和呼吸照護ICU重症培訓計劃</li>
<li>強化severe dengue的診斷及照護能力，以減少重症死亡比率</li>
</ul></li>
<li><strong>Dengue fever流行病學概況</strong>（破碎不完整的資訊，突顯建立統一監測系統的重要性）
<ul>
<li>2023年10月-12月：2,635例病例（734例陽性，陽性率27.9%）</li>
<li>2023年9月-2024年1月：6,394例疑似病例(WHO)</li>
<li>2022年10月-2024年6月：HGH報告2,871例病例(沒有實驗室data)</li>
<li>WHO提供20,000個RDT，HGH實驗室分配到1,512個（陽性率25.9%）</li>
</ul></li>
</ol>
</section>
<section id="action-pointswhowhen" class="level3">
<h3 class="anchored" data-anchor-id="action-pointswhowhen"><strong>Action Points</strong>(who/when)</h3>
<ol type="1">
<li><strong>eIDSR系統整合</strong> (MoHD Public Health / 2024年10月前)
<ul>
<li>優先在HGH lab建立RDT-confirmed dengue cases surveillance system</li>
<li>規劃DHIS2與ICDF HIS在4家公立醫院的整合</li>
<li>KPI：HGH lab系統建立完成度，即時數據dashboard功能正常運作</li>
</ul></li>
<li><strong>mHealth技術推廣</strong> (TMM / 2024年12月前)
<ul>
<li>在區域醫院、衛生中心和社區推廣DHIS2 tracker module app收集和報告技術</li>
<li>KPI：至少20%的public sectors in Hargeisa採用mHealth技術進行數據報告</li>
</ul></li>
<li><strong>登革熱RDT品質管制</strong> (HGH實驗室主任 / 2024年9月起)
<ul>
<li>建立RDT質量控制機制，解決false negative問題</li>
<li>確保臺灣供應RDT的有效使用和追蹤</li>
<li>KPI：降低偽陰性率至5%以下，RDT使用率達90%以上</li>
</ul></li>
<li><strong>加護病房能力建設</strong> (李枝新主任 / 2024年9-12月)
<ul>
<li>完成在地呼吸器和呼吸照護培訓計劃</li>
<li>強化severe dengue的診斷及照護流程</li>
<li>KPI：培訓至少10名ICU醫護人員，提高重症severe dengue存活率10%</li>
</ul></li>
<li><strong>建立data request機制</strong> (TMM + Dr.&nbsp;Hergeye / 2024年9月)
<ul>
<li>與MoHD確立明確的數據共享流程和申請表格</li>
<li>KPI：建立標準化數據共享協議，縮短dengue case reporting時間至每日通報</li>
</ul></li>
</ol>
</section>
<section id="計劃概述-archieved-20240807" class="level3">
<h3 class="anchored" data-anchor-id="計劃概述-archieved-20240807">計劃概述 (archieved) (2024/08/07)</h3>
<p>本計劃旨在支援索馬利蘭的登革熱防治工作，重點包括強化疾病監測系統、提升重症管理能力，並協助建立完善的資料收集和分析機制。</p>
</section>
<section id="主要內容更新" class="level3">
<h3 class="anchored" data-anchor-id="主要內容更新">主要內容更新</h3>
<ol type="1">
<li><strong>登革熱疫情監控（IDSR and eIDSR）</strong>
<ul>
<li>協助MoHD實施整合性疾病監測與應對（IDSR）系統</li>
<li>支援eIDSR在4家公立醫院的整合：Hargeisa、Boroma、Berbera和Burco (ICDF HIS)</li>
<li>推動mHealth於區域醫院、衛生中心和社區的應用</li>
</ul></li>
<li><strong>加護病房重症支援</strong>
<ul>
<li>提供動脈血液氣體分析試劑，用於加護病房重症患者</li>
<li>協助引進登革熱NS1快速診斷測試（RDT）(避免價廉品質不佳的產品)</li>
<li>支援HGH實驗室進行IgM/IgG抗體ELISA檢測</li>
<li>由李枝新主任主導呼吸器和呼吸照護 ICU重症培訓計劃</li>
</ul></li>
<li><strong>Dengue feverf流行病學概況</strong> 破碎不完整的資訊
<ul>
<li>2023年10月-12月：2,635例病例（734例陽性，陽性率27.9%）</li>
<li>2023年9月-2024年1月：6,394例疑似病例(WHO)</li>
<li>2022年10月-2024年6月：HGH報告2,871例病例(沒有實驗室data)</li>
<li>WHO提供20,000個RDT，HGH實驗室分配到1,512個（陽性率25.9%）</li>
</ul></li>
</ol>
</section>
<section id="action-pointswhowhen-1" class="level3">
<h3 class="anchored" data-anchor-id="action-pointswhowhen-1"><strong>Action Points</strong>(who/when)</h3>
<ol type="1">
<li><strong>eIDSR系統整合</strong> (MoHD Public Health / 2024年10月前)
<ul>
<li>規劃DHIS2與ICDF HIS在4家公立醫院的整合</li>
<li>KPI：系統整合完成度，即時數據dashboard功能正常運作</li>
</ul></li>
<li><strong>mHealth技術推廣</strong> (TMM / 2024年12月前)
<ul>
<li>在區域醫院、衛生中心和社區推廣DHIS2 tracker module app收集和報告技術</li>
<li>KPI：至少20%的public sectors in Hargeisa 採用mHealth技術進行數據報告</li>
</ul></li>
<li><strong>登革熱RDT品質管制</strong> (HGH實驗室主任 / 2024年9月起)
<ul>
<li>建立RDT質量控制機制，解決false negative問題</li>
<li>KPI：降低偽陰性率至5%以下</li>
</ul></li>
<li><strong>加護病房能力建設</strong> (李枝新主任 / 2024年9-12月)
<ul>
<li>完成在地呼吸器和呼吸照護培訓計劃</li>
<li>KPI：培訓至少10名ICU醫護人員，提高重症severe dengue存活率10%</li>
</ul></li>
<li><strong>建立 data request 機制</strong> (TMM + Dr.&nbsp;Hergeye / 2024年9月)
<ul>
<li>與MoHD確立明確的數據共享流程和申請表格</li>
<li>KPI：建立標準化數據共享協議，縮短dengue case reporting 時間至每日通報</li>
</ul></li>
</ol>
</section>
<section id="醫療外交亮點" class="level3">
<h3 class="anchored" data-anchor-id="醫療外交亮點">醫療外交亮點</h3>
<ol type="1">
<li><strong>跨國醫療合作典範</strong>
<ul>
<li>技術團、醫療團與索馬利蘭衛生部合作，展現台灣醫療軟實力</li>
<li>KPI：促成至少3項技術轉移協議，提升索馬利蘭公共衛生能力</li>
</ul></li>
<li><strong>數位醫療外交</strong>
<ul>
<li>推動eIDSR系統整合，展現台灣ICT優勢</li>
<li>KPI：系統使用率達85%，提高疾病監測效率30%</li>
</ul></li>
<li><strong>人道援助貢獻</strong>
<ul>
<li>通過重症管理能力建設，直接改善當地醫療品質</li>
<li>KPI：重症登革熱病例死亡率下降10%</li>
</ul></li>
</ol>
<!--
4. **永續發展目標響應**
   - 符合聯合國SDG3（健康與福祉）目標，提升國際能見度
   - KPI：在國際衛生組織會議中，至少2次報告計劃成果

通過以上行動計劃和外交亮點包裝，本計劃不僅能有效改善索馬利蘭的登革熱防治能力，還可以彰顯台灣在國際醫療合作領域的重要貢獻，提升台灣的國際形象和影響力。
 -->
<ul>
<li>加護病房重症支援:
<ul>
<li>動脈血液氣體分析試劑,供加護病房重症患者使用; 篩檢 dengue fever NS1 rapid diagnostic test (RDT); HGH laboratory (IgM/IgG antibody ELISA)</li>
<li>Ventilator and respiratory care in ICU: 李枝新主任主題醫療</li>
</ul></li>
<li>瓶頸(資訊破碎、不完整):
<ul>
<li>MoHD, Director General, Dr.&nbsp;Hergeye, Public Health department 接洽中;</li>
<li>dengue fever statistics;</li>
</ul></li>
<li>Epidemiological Overview: Case reports and trends
<ul>
<li>October-December 2023: 2,635 cases (734 positive, <strong>27.9%</strong>) (WHO, Somaliland)</li>
<li>September 2023-January 2024: <strong>6,394 suspected</strong> cases (WHO, Somaliland)</li>
<li><strong>October 2022</strong>-June 2024: 2,871 cases at HGH, Hargeisa
<ul>
<li>WHO provision of 20,000 RDTs (December 2023) =&gt; HGH laboratory usage: 1,512 tests (<strong>25.9% positive rate</strong>)</li>
</ul></li>
</ul></li>
</ul>
<p><img src="images/Week 5_ HC-Epidemiological_dengue_Somaliland.jpg" style="width: 100%; height: auto;"> (image courtesy: https://reliefweb.int/report/somalia/cholera-dengue-diphtheria-disease-outbreak-response-somalia-hc-meeting-15-02-2024) <!--
<iframe src="docs/2024Project_DengueFever_Hargeisa-tikz.pdf" type="application/pdf" width="100%" height="100%"></iframe>


<img src="images/2024Project_DengueFever_Hargeisa-tikz.jpg" style="width: 100%; height: auto;">
--></p>
<!--
{bash}
#| echo: false
#| output: false
pdfseparate -f 2 -l 2 ~/2024MSC/docs/2024Project_DengueFever_Hargeisa-tikz.pdf ~/2024MSC/docs/2024Project_DengueFever_Hargeisa-tikz_p2.pdf

-->
<!-- 暫時不用
![MoHD public sector](2024Project_DengueFever_Hargeisa-tikz_p2.pdf){#fig-tikz width=100% height=100%}
-->
<ul>
<li><strong>Action points</strong>(who/when): [2024/07/24]:</li>
</ul>
<ol type="1">
<li>2023年Somaliland登革熱資料收集:
<ul>
<li>與WHO和MoHD確認2023年完整資料可獲得性 (TMM / 2024/07/31)</li>
<li>分析資料獲取困難點，提出解決方案 (TMM / 2024/08/15)</li>
</ul></li>
<li>2024年疫情準備:
<ul>
<li>制定2024年登革熱應對計劃 NS1 rapid diagnostic test (TMM / 2024/08/31)</li>
<li>評估現有資源和準備程度 (TMM / 2024/08/15)</li>
<li>建立疫情監測系統改進計劃eIDSR (TMM / 2024/09/15)</li>
</ul></li>
<li>萬芳醫院支援需求:
<ul>
<li>列出所需技術支援清單 (TMM / 2024/07/31)</li>
<li>與萬芳醫院討論遠距諮詢(感染科醫師) (TMWH / 2024/08/15)</li>
<li>制定培訓計劃，提升當地醫護人員能力 (TMWH / 2024/09/30)</li>
</ul></li>
<li>資料分析和報告:
<ul>
<li>分析HGH 2022年10月至2024年6月的2,871例病例資料 (TMM / 2024/08/31)</li>
<li>評估WHO提供的20,000 RDTs使用情況，特別是HGH實驗室使用的1,512測試 (TMM / 2024/08/15)</li>
<li>製作綜合報告，包括流行病學概況和趨勢分析 (TMM / 2024/09/30)</li>
</ul></li>
<li>資源管理:
<ul>
<li>評估現有RDTs庫存和未來需求 (TMM / 2024/07/31)</li>
<li>制定資源分配策略，確保有效利用有限的RDTs (TMM / 2024/08/15)</li>
</ul></li>
</ol>
<p>[2024/07/10]</p>
<ol type="1">
<li>2023年索馬利蘭 WHO Dengue fever 資料蒐集: (Taiwan Medical Mission)</li>
</ol>
<ul>
<li>2635 cases of dengue fever were reported in Somaliland <strong>October to December 2023</strong> of which 734 were tested <strong>positive (27.9%)</strong> for dengue by rapid diagnostic test (RDT) kit. The most affected districts are Hargeisa, Boroma and Gebiley. (https://reliefweb.int/report/somalia/who-somalia-health-emergency-programme-update-december-2023)</li>
<li><strong>6394 cases of suspected dengue fever</strong> were reported in Somaliland <strong>September 2023 to January 2024</strong> (5 months period, <strong>peak on November 2023</strong>; https://reliefweb.int/report/somalia/cholera-dengue-diphtheria-disease-outbreak-response-somalia-hc-meeting-15-02-2024)</li>
<li>WHO Dr.&nbsp;Deq: 醫療團已於2024/06/18拜會
<ul>
<li>建議與指示:
<ul>
<li>WHO and TMM to maintain open communication and collaboration in supporting MoHD’s efforts to control the dengue fever outbreak in Somaliland.</li>
<li>WHO: the shared data on dengue fever cases from October 2023 and identify potential areas for support in the surveillance system.</li>
<li>Dr.&nbsp;Deq strongly recommends that <strong>TMM focuses on supporting the weakest part</strong> of the Ministry of Health and Development (MoHD): <strong>the dengue fever surveillance system</strong>, from community and regional levels to MoHD.</li>
<li><strong>Electronic Integrated Disease Surveillance and Response (eIDSR)</strong>: <a href="https://texchi2.github.io/2024MSC/2022_2024_dengue_statistics_HGH.html" target="_blank">meeting minutes</a></li>
</ul></li>
</ul></li>
</ul>
<ol start="2" type="1">
<li>索馬利蘭衛生部/HGH: (Taiwan Medical Mission / 2024/06/27)
<ul>
<li>2023年疫情資料整理是準備2024年行動的關鍵，包含檢測數據、<strong>陽性率</strong>、地區分佈。</li>
<li>追蹤December 2023年快篩試劑 20,000 test of RDTs的使用：受測者demographic data，快篩試劑分配方式，UNICEF培訓人員(110 health workers)的現狀，參考上述 as national adaptation，以做出2024應變的計劃。
<ul>
<li>經查 <strong>HGH laboratory 取得僅 1512 test</strong> of dengue NS1 RDT (December 2023 to 27 June 2024): <strong>陽性率 25.9%</strong></li>
<li>其他的 18,488 RDTs 分配方式不明(MoHD DG Dr.&nbsp;Hergeye 經當面詢問，答稱不清楚)</li>
<li><strong>MoHD Dr.&nbsp;Hergeye and Public health department</strong> Mr.&nbsp;Mahdi Dahir Bahdoon ( [2024/08/01]會議: https://texchi2.github.io/2024MSC/20240729_MoHD_TMM_agenda_eIDSR.html): <strong>eIDSR surveillance</strong></li>
</ul></li>
<li>TMM project 資金利用：若不適合IRS(indoor residual spray)，預算資金可轉向其他更合適的防疫措施 =&gt; IDSR</li>
</ul></li>
<li><strong>2022-2024年(June) HGH 登革熱</strong>統計報告:(Taiwan Medical Mission / 2024/06/15)</li>
</ol>
<ul>
<li>由 HGH NCD director Dr.&nbsp;Ahmed Hersi(紙本登記簿)提供其分析結果<strong>[2024/06/13]</strong>:
<ul>
<li><p>From October 2022 to June 2024, a total of <strong>2,871 patients with dengue fever were registered at HGH (test? unknown)</strong>. Among these patients, 1,232 (42.9%) were male, and 1,639 (57.1%) were female.</p></li>
<li><p>The majority of patients (2,036, 70.9%) received outpatient medical services, while 835 (29.1%) required hospital admission due to the severity of their illness.</p></li>
<li><p>The age distribution of the patients was as follows: 1,723 (60.0%) were under 30 years old, 774 (27.0%) were between 31 and 50 years old, and 374 (13.0%) were over 50 years old.</p></li>
<li><p>The total number of <strong>dengue fever-related deaths</strong> was 23, with a higher mortality rate observed among female patients.</p></li>
</ul></li>
<li>已進一步<strong>向 Dr.&nbsp;Ahmed 索取raw data (since 14 June 2024)</strong> 以便進行完整分析<strong>陽性率</strong>、以及risk category of severe dengue。</li>
</ul>
<ol start="4" type="1">
<li>[2024/06/11] HGH 小兒科統計報告:(Dr.&nbsp;Mohamed and Dr.&nbsp;Guuled, and Dr Hamda)(revision by Taiwan Medical Mission / 2024/06/26)</li>
</ol>
<ul>
<li>2024 May/June 累積的小兒登革熱案例(十八歲以下)，計有
<ul>
<li>139 confirmed cases on May and June (by NS1 in private sector, or IgG/IgM test in HGH)</li>
<li>8 severe dengue cases (5.8%): upper/lower GI bleeding, plasma leakage, myocarditis (due to congenital heart disease), encephalitis, diabetic ketoacidosis (in type 1 diabetes)</li>
<li>0 mortality (0%)</li>
</ul></li>
</ul>
<ol start="5" type="1">
<li>HGH dengue fever strategy SOP :(HGH / ongoing)
<ul>
<li>現行 (2022) HGH Dengue fever management guideline</li>
</ul></li>
</ol>
<!--     
     (@fig-dengue)
   <img src="images/IMG_3003.png" style="width: 100%; height: auto;">

 ![Dengue Fever SOP](docs/2022_HGH_Dengue_fever_Guidline.pdf){#fig-dengue width=110%}

@fig-tikz

    - USD2.5 per test for **Dengue NS1 RDT** 快篩、檢驗與血庫
    - 藥品(**缺乏小兒科藥品**/**小兒科醫師們自費購買**)
    - 開設隔離病房須設施（床單、蚊帳、insecticide spray、衛生、重症support）
-->
<ol start="6" type="1">
<li>索馬利蘭行政區劃分與醫療資源分佈:</li>
</ol>
<ul>
<li>6 regions in Somaliland。</li>
<li>Maroodijeeh Region分為2個District。</li>
<li>Hargeisa為一獨立District,下設8個行政區(Sub-district)。</li>
</ul>
<ol start="7" type="1">
<li>進行Hargeisa行政區域及各層級醫療機構分佈調查:<br>
</li>
</ol>
<ul>
<li>Hargeisa District 內各層級(RHC, HC, PHU or MCH)醫療機構家數
<ul>
<li>3 regional hospital (Naaso Hablood Hospital, Gurmad Hospital, and Daryeel Hospital)</li>
<li>3 Referral Health center (RHC), 3 Health Center (HC), 45 Primary Health Unit (PHU) <strong>non-functional</strong>, and 66 Maternal Child Health clinics (MCH)</li>
</ul></li>
<li>瞭解各行政區可及的醫療資源,作為登革熱防治規劃的參考。</li>
</ul>
<ol start="8" type="1">
<li>Somaliland Publications<br>
</li>
</ol>
<ul>
<li>來自本土發表的文章: <strong>醫療團已與作者取得聯繫 Mr.&nbsp;Hussein Mohamoud Nour</strong> 2022 Edna Adan University Hospital (EAH) statistics, a research article titled “Sero-prevalence of Dengue virus infection and associated factors among patients with febrile illness attending at Edna Adan University Hospital. Hargeisa, Somaliland, 2022: A cross-sectional study” published in the Journal of Women’s Health Care. (https://www.longdom.org/open-access-pdfs/seroprevalence-of-dengue-virus-infection-and-associated-factors-among-patients-with-febrile-illness-attending-at-edna-ad.pdf)</li>
<li>[2024/06] <strong>dengue NS1 RDTs is only available in few private hospitals</strong></li>
<li>(尚未回應) 就教於當地專家 Dr Yusuf Mohamed (Infectious disease and tropical medicine) in Hargeisa, he attended 2024MSC as a participant)</li>
</ul>
<!--
  6. UNICEF協助
   - **已循適當管道引薦**
   - 避免涉及敏感的**一個中國議題**
   - 以專業中立的醫療人道立場,爭取UNICEF支持
   - vector control in Somaliland, implemented by UNCEF on October 2023
-->
<div style="page-break-after: always;"></div>
<p>*<strong>訓練</strong></p>
</section>
</section>
<section id="visiting-scholarships-for-training-in-taiwan" class="level2">
<h2 class="anchored" data-anchor-id="visiting-scholarships-for-training-in-taiwan">2. Visiting Scholarships for Training in Taiwan</h2>
<ul>
<li>Project: Capacity Building for Somaliland Medical Personnel</li>
<li>Collaborators: Taipei Municipal Wanfang Hospital (TMWH), Taiwan Medical Mission (TMM), and Hargeisa Group Hospital (HGH)</li>
<li>Initiatives:
<ol type="a">
<li>Provide “Visiting Scholar Scholarships” for 12 Somaliland medical personnel to receive training in Taiwan for up to three months</li>
<li>Conduct selection process jointly by Taiwan Medical Mission and HGH Director’s Office</li>
<li>Invite selected personnel to participate in <strong>TMM’s 2024 public health programs</strong></li>
</ol></li>
<li>Required support:
<ol type="a">
<li>TMM: Scholarship funding for 12 medical personnel (one batch)</li>
<li>Coordination with TMWH for training arrangements</li>
<li>Collaboration with HGH for personnel selection and public health program participation</li>
</ol></li>
</ul>
<!--    d. **MoU** between HGH and TMWH
    
    e. 12 scholarship candidates:
      - Batch 1 (June to September)
        - Dr. Abdulrahmaan Adoosh Abdulaahi (Resident, Orthopedic)
        - Dr. Hassan Mohamoud Nour (Resident, Orthopedic)
        - Dr. Nouh Ismail Mohamed (General Surgery)
        - Mr. Ahmed Hussein Jama (Nurse, OT director)
      
      - Batch 2 (September to November)
        - Dr. Mustafe Ahmed Yusuf (Neurosurgery) => spine surgery
        - Dr. Abdihamid Mohamed Ali (Neurosurgery) => cranial surgery
        - Dr. Adnan Sayid Abdo (General Surgery) => **laparoscopic training**
        - Dr. Idiris Hassan Dahir (Cardiologist)

      - Batch 3 (October to December)
        - Mr. Mustafe (Technician, Pathology)
        - Dr. Omer Mohamed Bihi (Pathology)
        - Dr. Saed Mohamed Osman (Resident, Orthopedic)
        - Dr. Mohamed Hassan Nur (Resident, Orthopedic)
-->
<!--
        - Dr. Abdirahman Mohamed Osman (**Hospital Director**)
        - Dr. Khadar Good Nur (Infection Prevention Centre Director)

  - gantt chart (2024):@fig-gantt
-->
<!-- 
<img src="images/2024TMM_12scholars_gantt3.jpg" style="width: 100%; height: auto;">
-->
<!--
![gantt for 2024 visiting scholars](docs/2024TMM_12scholars_gantt3.pdf){#fig-gantt width=110%}
-->
<ul>
<li><strong>Action points</strong>(who/when):</li>
</ul>
<!--  1. **(HOLD)**第一批次預計 2~4 名醫師送訓，已完成七日公開招標(@Geeska Africa 網頁)，[2024/06/14]於開標、決標後將依照，衛生福利部**核可人員名單**，準備辦理機票採購及Taiwan VISA申請作業。預計二名醫師(骨科 Dr. Hassan 及一般外科 Dr. Nouh)將於 2024/06/23 之前抵達臺北。預計九月20日完成訓練。(Taiwan Medical Mission / 2024/06/16)
-->
<ol type="1">
<li>(謝謝病理科陳主任指導)遠距視訊會議(<strong>2024/6/20</strong>，瞭解HGH pathology 之 staff 和設備，進一步溝通合作細節)。取得 Dr Omar 電子版的 病理報告，Microsoft Access database 並完成分析，近半年僅有 110 份報告，4/5 都未能存檔；所幸尚有紙本報告留存在 file folder (已經由Dr. Omar手工輸入，轉為 Excel file， 亦已於 2024MSC 研討會中初步 報告): 110 名病例分析 <a href="https://texchi2.github.io/2024MSC/2024Project_HGH_pathology_LIMS.html" target="_blank">from MS Access database</a></li>
</ol>
<ul>
<li>正在安排第一次 telepathology meeting for case discussion (Dr.&nbsp;Omar, <strong>since 20 June</strong>)</li>
<li>正在邀請Dr. Omar 分享上述 Excel data (<strong>Dr.&nbsp;Omar, since 20 June</strong>)</li>
</ul>
<ol start="2" type="1">
<li><p>送訓科別(尚缺培訓計劃書):神經外科、病理科、骨科</p></li>
<li><p>送訓科別(已有培訓計劃書):一般外科(2 or 3名主治醫師)、ICU/胸腔內科(待進一步說明 Dr.&nbsp;Jacfar)、開刀房護理師(一名)</p></li>
<li><p>建議送訓科別: 心臟內科(例如，心臟內科醫師的培訓需要考慮HGH現有的設備情況，如超音波機器的類型。)</p></li>
<li><p>為確保受訓者回國後能實際運用所學技能的重要性。各科的培訓計畫中，須明確訂立每位受訓者回國後的服務目標。</p></li>
</ol>
<!--  、HGH研究中心(醫師、護理師、助產士) -->
<p><!-- 腫瘤科chemotherapy Dr. Ahmed Hersi --></p>
<ol start="6" type="1">
<li>一般外科腹腔鏡手術訓練中心 - 由醫療團王彥翔醫師與HGH Afnan醫師及一般外科醫師群(包括十月份將赴臺北的 Dr.&nbsp;Nouh)，合作推行 - 背景:HGH一般外科醫師具豐富開刀經驗,但受限於資源,公立醫院尚無腹腔鏡設備<br>
- 所需設備:萬芳醫院提供腹腔鏡手術器械與訓練模型(home made DIY simulator box)<br>
- <strong>Action points</strong>(who/when):
<ul>
<li>待課程規劃、器械整理後，開始訓練教學 (Taiwan Medical Mission / 2024/07)</li>
<li>通過認證者，得遴選為<strong>赴臺送訓</strong>的種子學員(上限三名)</li>
</ul></li>
</ol>
<!--  2. 醫療團建議，2024年度若仍有設備款預算，提列**腹腔鏡手術設備**援贈新開刀房使用 -->
<ol start="7" type="1">
<li>待遴選完成後，辦理健康檢查(Chest X-ray, Tuberculosis (TB) Sputum Test, Syphilis/VDRL, Measles/Rubella)，以利申請 90日之受訓，執行臨床實作) (預計為十月份開始受訓)(Taiwan Medical Mission / 2024/07)</li>
</ol>
<!--  7. **HGH 院長 Dr. Abdirahman**: 希望能於八月份赴萬芳醫院(二週)，接受醫院經營管理之培訓。(TMWH / 2024/07)
  
  8. 新成立的 **HGH研究中心 research center**: 並肩負 IRB 的功能
  - online virtual meeting with TMWH研究部, 訓練研究人員使用分析工具 / Train researchers in using analytical tools
  - visiting scholars (Taiwan Medical Mission / 2024/08)
-->
<!--      - 希望能於七月份，赴**代表處**拜見羅大使，進一步針對醫療團於HGH的年度計劃，交換意見
      
  3. 訓練分四批進行：第一批六月中、七、八、九月，第二批預計在七、八月、九月，第三批在九、十、十一月，第四批十、十一、十二月。(Taiwan Medical Mission / 2024 by gantt chart)

  4. 預計三位醫師、一位護理師的培訓時間為89天，因低於三個月，無法進行臨床實務操作。

    - 2024/06/13 已完成萬芳醫院骨科陳昱斌副主任、與索馬利蘭骨科醫師視訊會議，確認來台培訓細節，雙方獲得共識，以符合其骨科訓練計畫的既定「年度指定課程」

    - Dr. Nouh Ismail Mohamed (General Surgery) 23 Jun - 20 Sep =>
衛福部已核可(89 days 無須健康檢查報告,不執行臨床實作) 已準備採購機票，辦理 VISA 出發(Taiwan Medical Mission / 2024/06/20)

    - Dr. Hassan Mohamoud Nour (Resident, Orthopedic) 23 Jun - 20 Sep  =>衛福部已核可(89 days 無須健康檢查報告,不執行臨床實作; 亦經骨科 陳副主任認可) 已準備採購機票，辦理 VISA 出發(Taiwan Medical Mission / 2024/06/20)

    - Dr. Abdulrahmaan Adoosh Abdulaahi (Resident, Orthopedic)  => 請申請 七月中旬開始受訓 (89 days 無須健康檢查報告,不執行臨床實作)(陳尚臻事業發展部  / 2024/06/20)

    - Mr. Ahmed Hussein Jama (Nurse, OT director) => 請申請 七月中旬 開始受訓 (89 days 無須健康檢查報告,不執行臨床實作)(陳尚臻事業發展部  / 2024/06/20)

  5. 其餘人員，待2024/06/15各別通知後，辦理健康檢查(Chest X-ray, Tuberculosis (TB) Sputum Test, Syphilis/VDRL, Measles/Rubella)，以利即日起申請 90日之受訓，執行臨床實作) (預計為九月，十月開始受訓)(Taiwan Medical Mission / 2024/06/21)
 
  
  5. 骨科醫師分批赴臺，每次最多兩位，兩批次（第一/二，及第四批）日期不重疊，以維持骨科正常運作與服務，且能於2024年度完成專科訓練的**必修課程**，以參加年底的**年度晉級考試**。(Taiwan Medical Mission / 2024 by gantt)
    -->
<div style="page-break-after: always;"></div>
<p>*<strong>示範</strong></p>
</section>
<section id="骨質健康計劃" class="level2">
<h2 class="anchored" data-anchor-id="骨質健康計劃">3. 骨質健康計劃</h2>
<p>A. 由萬芳醫院骨科郭宜潔醫師/陳昱斌醫師指導HGH骨科團隊<br>
- 計畫內容:關節鏡膝關節手術<br>
- 所需設備: 膝關節鏡手術器械(ready)<br>
- 目前進度:2023年10月郭醫師親自示範手術技巧,培訓種子醫師;2024年8月骨科專家將再度蒞臨指導進階手術<br>
- 瓶頸: - 醫師學習曲線較長,需反覆練習; - 關節鏡設備維修保養需OT的醫學工程技術員、及開刀房主任（護理師)負責</p>
<p>B. TOM 骨質疏鬆預防保健計畫<br>
- 計畫名稱:「TOM骨質疏鬆」篩檢與預防保健<br>
- 內容:利用股骨X光片,透過<strong>AI人工智慧</strong>計算T-score/Z-score,評估骨質密度<br>
- 目前進度:已引進Taiwan Osteoporosis Master (TOM)系統,規劃舉辦<strong>義診以推廣活動</strong><br>
- 瓶頸:民眾對骨質疏鬆認知不足,由骨科與放射科醫師支援，於院內骨科門診、骨科住院病患衛教宣導做起，並架設系統與網路讓 TOM上線</p>
<ul>
<li><p>case control study in hip fracture (retrospective)</p>
<ol type="1">
<li><p>先行建立骨質疏鬆檢測系統(TOM: pelvic x-ray 建議拍攝參數 kVp:85, mAs:30, SID:100cm),並完成設備與網路架設(intranet)。</p></li>
<li><p>首月執行義診服務，由醫療團補貼放射科股骨X光片及放射科主治醫師的診斷費用。</p></li>
<li><p>進行髖部骨折病例對照研究(Hip fracture Case control study),調查分析當地骨質疏鬆盛行現況。</p></li>
<li><p>根據研究結果,與骨科團隊討論後續執行方向,擬定符合在地需求的骨鬆防治策略。</p></li>
</ol></li>
<li><p><strong>Action points</strong>(who/when): TMM / 2024/08</p></li>
</ul>
<div style="page-break-after: always;"></div>
<p>*<strong>公共衛生</strong></p>
</section>
<section id="三項癌症防治計畫子宮頸癌乳癌肝癌" class="level2">
<h2 class="anchored" data-anchor-id="三項癌症防治計畫子宮頸癌乳癌肝癌">4. 三項癌症防治計畫(子宮頸癌、乳癌、肝癌)</h2>
<section id="a.-子宮頸癌防治中心乳癌" class="level4">
<h4 class="anchored" data-anchor-id="a.-子宮頸癌防治中心乳癌">A. 子宮頸癌防治中心、乳癌</h4>
<ul>
<li><p>由HGH Fatima醫師、台灣醫療團王彥翔醫師(一般外科)、黃郁昕醫師(婦產科團員)共同推動</p></li>
<li><p>子宮頸癌篩檢:引進HPV DNA real-time PCR檢測、Pap smear抹片染色與細胞病理訓練課程</p></li>
<li><p>子宮頸癌預防:引進HPV vaccine</p></li>
<li><p>乳癌篩檢:乳房超音波檢查</p></li>
<li><p>瓶頸:</p>
<ul>
<li>cancer registry and cancer statistics:
<ul>
<li>Somalia tertiary hospital report: (2017-2020, n=1306; <strong>13.1%</strong> breast cancer, <strong>13.3%</strong> cervical cancer), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534047/</li>
<li>2023/03/10 WHO ICO/IARC report for Somalia Statistics of HPV-related cancers, crude incident rate of cervical cancer <strong>13.2 per 100,000</strong> population, ranked 2nd (https://hpvcentre.net/statistics/reports/SOM_FS.pdf); IARC: International Agency for Research on Cancer. ICO: Catalan Institute of Oncology</li>
<li>Carroll et al., 2007: barrier for screening (https://pubmed.ncbi.nlm.nih.gov/17454183)</li>
<li>Ghebre RG et al., 2015 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312274/)</li>
<li>Cervical cancer in Somaliland (literature review): https://texchi2.github.io/2024MSC/2024Project_HPV.html</li>
<li>2022 report by Needle hospital in Hargeisa: Gebrekirstos Hagos et al., 2023 (https://ecancer.org/en/journal/article/1642-cancer-care-in-needle-hospital-hargeisa-somaliland)</li>
</ul></li>
<li>病理科 Dr.&nbsp;Omar (report 2 cases in 2023)請求支援，<strong>病理切片遠距</strong>會議; Dr.&nbsp;Omar and Mr.&nbsp;Mustafe (technician) 亦在2024 <strong>送訓名單</strong>中 (visiting scholars)</li>
<li>WHO’s suggested <strong>HPV疫苗</strong>需要尋求來源GAVI (Hargeisa primary school girls aged 9-14: 50,000 persons; 資料來源 2023 statistics from Ministry of Education and Science, MoES);</li>
<li>民眾健康觀念需宣導，並必須與 sexual transmission 切割明確，以免因民情保守，讓 推行受到阻礙</li>
</ul></li>
</ul>
<!--

![Draft proposal by Dr. YuHsin](docs/Initiate Reproductive Cancer Screening and Early Detection in Somaliland 0612.pdf){#fig-hpv width=110%}
-->
<ul>
<li><p>Current Information</p>
<ol type="1">
<li>reviewed articles</li>
</ol>
<ul>
<li>Carroll et al., 2007: barrier for screening (https://pubmed.ncbi.nlm.nih.gov/17454183)</li>
<li>Ghebre RG et al., 2015 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312274/)</li>
<li>Cervical cancer in Somaliland (literature review): https://texchi2.github.io/2024MSC/2024Project_HPV.html</li>
<li>分享HPV center相關文獻,作為推動子宮頸癌防治的參考(https://hpvcentre.net/statistics/reports/SOM_FS.pdf)</li>
</ul>
<ol start="2" type="1">
<li>調查HGH病理報告現況:</li>
</ol>
<ul>
<li>了解組織切片檢查(biopsy)後,病理報告的完整性。</li>
<li>調查是否有出具報告、判讀結果、或報告遺失等情形。</li>
<li>建議先由萬芳醫院陳主任，與Dr. Omar 建立遠距病理討論(tele-pathology)，建立合作關係與互信</li>
<li>評估是否可完整收集既有病理報告,以利後續分析。</li>
<li>建議由駐地護理師協助整理及彙整相關資料。</li>
</ul>
<ol start="3" type="1">
<li>安排與索馬利蘭駐地病理科視訊會議(tele-pathology conference):</li>
</ol>
<ul>
<li>邀請臺北病理科陳威宇主任,與索馬利蘭駐地團隊進行視訊討論。</li>
<li>HGH 病理科現有 digital slide scanner。</li>
<li>HGH 病理科僅有 H&amp;E and cytology stain (Pap stain)服務，無IHC staining。</li>
<li>就子宮頸癌防治、病理診斷等議題交換意見,提供專業建議。</li>
<li>Dr.&nbsp;Omar與病理技術員 Mr.&nbsp;Mustafe亦在2024送訓臺北的學員名單中。</li>
</ul>
<ol start="4" type="1">
<li>調查索馬利蘭HGH病理專科醫師Dr. Omar到任後(2023/02),病理檢體概況:<br>
</li>
</ol>
<ul>
<li>統計Dr. Omar到任後,病理切片的數量、檢體種類、部位、類型等資訊。</li>
<li>瞭解目前HGH病理科的檢驗量能與診斷需求。</li>
<li>彙整調查結果,與臺北病理科陳主任討論,研擬合作策略。</li>
<li>Dr.&nbsp;Shih-Han Hung 萬芳醫院ENT洪主任，自2023/08 到訪之後，與Dr. Omar 持續連絡，或許已有相關的統計成果，與發表文章。建議請副院長詢問一下。</li>
</ul>
<ol start="5" type="1">
<li>子宮頸癌防治計畫推動方式:</li>
</ol>
<ul>
<li>Pap smear/Pap stain (ready)</li>
<li>HPV DNA</li>
<li>HPV vaccine</li>
<li>建議由OBGYN director Dr.&nbsp;Fatima醫師主動啟動,透過宣導及篩檢提高覆蓋率。</li>
<li>駐地護理師協助資料整理、追蹤及衛教等工作。<br>
</li>
<li>醫療團持續提供技術指導及所需資源(reagents),確保計畫順利進行。</li>
</ul></li>
</ul>
<!--
  6. Dr.YuHsin 黃醫師與HGH婦產科討論合作項目:
   - 黃醫師於2024/05/30抵任,2024/06/01與當地婦產科團隊Dr. Fatima重新討論合作範圍。
   - 針對子宮頸抹片(Pap smear)、乳房超音波(ultrasound for breast cancer screening)(醫療團Dr. Andrew 王醫師支援)等項目,擬定二合一篩檢執行策略。
   - draft proposal: <a href="https://texchi2.github.io/2024MSC/2024Project_HPV.html" target="_blank">Cervical Cancer in Somaliland: Burden, Barriers, and Opportunities for Prevention...</a>
-->
<ol start="6" type="1">
<li>子宮頸採檢、基因與細胞抹片檢查:</li>
</ol>
<ul>
<li>HPV DNA test (HGH院內檢驗科，現有Qiagen Rotor-Gene Q real-time PCR 儀器): 須要另外採購 HPV DNA PCR reagents。</li>
<li>由HGH病理科Dr. Omar負責判讀子宮頸抹片 Pap stain and cytology。</li>
<li>萬芳醫院病理科提供相關教學及技術支援。</li>
<li>定期盤點染色試劑存量,適時提出申請,避免斷貨。並持續培訓病理染色及判讀人員。</li>
<li>萬芳醫院定期監督品質,確保判讀結果的可靠性。</li>
</ul>
<!--
  7. HPV疫苗推動事宜:
   - 向外交部說明HPV疫苗的必要性及優勢(**獲得WHO, UNICEF, UNAIDS, IPPF肯定**的必要方式)。  
   - 與外交部達成共識,確定是否購買疫苗及所需數量。根據2023年調查，Hargeisa有5萬名9~14歲女學生(MoES教育部DG提供資料)
   - 黃醫師協助溝通,取得外交部支持後,向其報告推動方案。
   - WHO的90-70-90，是分成
      - Primary prevention: HPV vaccine
      - Secondary prevention: Cancer screening (cytology, VIA, HPV DNA testing) plus treatment for precancerous lesions (thermal ablation/warm therapy or CO2 laser/cold therapy, LEEP)
      - Tertiary prevention: Cancer management, including surgery, chemotherapy, radiotherapy, combined, and palliative care 
-->
<ul>
<li><strong>Action Points</strong>(who/when):</li>
</ul>
<ol type="1">
<li><p>分拆子宮頸癌和乳癌預防及早期診斷計畫 (Dr.&nbsp;Huang / 2024/07/13)</p></li>
<li><p>提升婦女健康，促進性別平等:</p>
<ul>
<li>設計社區健康工作者（Community Health Workers）和志工（Volunteers）培訓計畫 (RN Penny / 2024/08/15)</li>
<li>製作 Reproductive Cancer 健康教育材料 (RN Penny / 2024/08/31)</li>
<li>與 WHO 討論 HPV 檢測流程 (Dr.&nbsp;Huang / 2024/08/15)</li>
<li>設計完整的病患轉診流程 (Dr.&nbsp;Wang / 2024/08/31)</li>
<li>與私立醫院討論 mammography 和 chemotherapy 服務合作 (Dr.&nbsp;Huang / 2024/09/15)</li>
<li>建立 IDEM 資料庫計畫 (TMM / 2024/09/30)</li>
</ul></li>
<li><p>確保計畫持續性:</p>
<ul>
<li>在Dr. Huang 離開前可以做哪些; 離開之後誰可以做什麼 (2024/11)</li>
<li>與萬芳醫院婦產科及家醫科討論主題醫療支援可能性 (Dr.&nbsp;Huang / 2024/07/11)</li>
<li>試擬定當地計劃經理人聘用計畫 (Dr.&nbsp;Huang / 2024/08/15)</li>
<li>設計當地病理科醫師培訓計畫 (TMWH / 2024/07/31)</li>
</ul></li>
<li><p>預算和設備:</p>
<ul>
<li>修改預算，分別列出子宮頸癌和乳癌項目 (Dr.&nbsp;Huang / 2024/07/12)</li>
<li>加快必要設備採購流程，包括 HPV DNA kits (TMWH / 2024/08/01)</li>
<li>完成 2024 年 Phase 1 預算 (Dr.&nbsp;Huang / 2024/08/31)</li>
<li>編製 2025 年 Phase 2 計劃與預算書 (Dr.&nbsp;Huang / 2024/11/20)</li>
</ul></li>
<li><p>研究和報告:</p>
<ul>
<li>制定研究計畫，準備SCI國際期刊發表 (Dr.&nbsp;Huang / 2024/10/31)</li>
<li>完成 2024 年期中報告 (Dr.&nbsp;Huang / 2024/11/20)</li>
</ul></li>
</ol>
<!--
[2024/07/10]
- **Action points**(who/when):

1. 在2022 TMM 建立的基礎上，推進乳癌及子宮頸癌的預防和早期診斷。

2. 提升婦女健康，促進性別平等:
  - 透過社區健康工作者（Community Health Workers）和志工（Volunteers）散播健康資訊。
  - RN Penny負責此部分的健康教育工作。
  - Reproductive Cancer是一個新的議題，RN Penny將幫忙找尋種子學員或社區成員來進行資訊傳播。
  - 確保民眾了解Cervical Cancer和Breast Cancer的篩檢工具及操作流程，並與WHO討論HPV檢測。
  - 設計完整的病患流程，了解哪些情況可以在當地醫院處理，哪些需要轉介。
  - 當地僅於私立醫院有mammography和chemotherapy 服務。希望與這些機構進行合作、並進一步討論價格議題。
  - 評估預算後，將推廣Cervical Cancer和 Breast Cancer服務，並建立IDEM資料庫。
  - 建立Database並確保資料庫的sustainability。
  - 建議將研究成果在國際期刊發表，確保公共衛生實踐的存在性。
  - 考慮未來Dr. YuHsin 離任後，如何確保計畫能夠持續。
  - 考量到索馬利蘭的病理科醫師人數(僅三名)，宜優先進行HPV DNA 篩檢。
  - HGH laboratory 擁有real-time PCR cycler 機器(**Qiagen Rotor-Gene Q**, for research only)，但需購買耗材(HPV DNA kits)。
  - 與當地**病理科醫師**合作，建立持續合作關係。
  - 計畫Phase 1的預算，確保順利執行後，再進一步計畫Phase 2。(Taiwan Medical Mission / 2024/07)
-->
<div style="page-break-after: always;"></div>
</section>
<section id="b.-索馬利蘭病毒性肝炎viral-hepatitis篩檢與預防控制計畫" class="level4">
<h4 class="anchored" data-anchor-id="b.-索馬利蘭病毒性肝炎viral-hepatitis篩檢與預防控制計畫">B. 索馬利蘭病毒性肝炎(Viral Hepatitis)篩檢與預防控制計畫</h4>
<ul>
<li><p>經WHO Dr.&nbsp;Deq 主動提出合作意願，TMM並可邀請 NGO SAHA 合作</p></li>
<li><p>協助索馬利蘭制定 HBV 和 HCV 篩檢與預防控制的 <strong>national policy</strong></p></li>
<li><p>HGH最近成立了HBV門診</p></li>
<li><p>建立以哈格爾薩總醫院(HGH)為核心的 HBV 和 HCV 管理模式 + MoHD IDSR</p></li>
<li><p>提高醫護人員與民眾對 HBV 和 HCV 的認識和重視(健康飲食、不吸菸、不嚼食khat葉與菸草等，預防<strong>脂肪肝</strong>、有效預防肝臟發炎，阻止肝炎 、肝硬化、肝癌三部曲的危機。)</p></li>
<li><p>製作索馬利蘭語的宣傳手冊 (Booklet)</p></li>
<li><p>建立 HBV 帶原者的追蹤和 HCV病毒根除治療</p></li>
<li><p>計畫成果指標：</p>
<ul>
<li>完成 HBV 和 HCV 國家策略文件的制定(WHO 建議)</li>
<li>HGH (約500-700名醫護人員)院內完成 HBV/HCV 篩檢和 HBV 疫苗接種</li>
<li>加強 HGH HBV/HCV 門診運作(2024/04 已新成立)，並擴展至其他公立醫療機構，以及格爾薩大學醫學生和護理系學生(未來的第一線醫事人員)</li>
<li>製作並發放索馬利蘭語的健康教育手冊</li>
<li>IDSR 建立 HBV 帶原者追蹤系統，並開始 HCV病毒根除治療</li>
</ul></li>
<li><p><strong>Action Points</strong> (who/when)：</p>
<ul>
<li>HBV/HCV mini review: <a href="https://texchi2.github.io/2024MSC/2024Project_hepatitis.html" target="_blank">(Somalia, 2018)</a></li>
<li>向 MoHD 申請: HGH 門診(HIS) 統計資料分析 (TMM / 2024年7月)</li>
<li>從國家公共衛生部門、醫院實驗室和現有的HBV門診<strong>收集HBV/HCV盛行率等數據</strong></li>
<li>與 WHO、NGO SAHA 和 MoHD 共同制定 HBV 和 HCV 國家策略框架 (TMM、WHO Dr.&nbsp;Deq、SAHA Dr.&nbsp;Max、MoHD 公衛主任 / 2024年8月)</li>
<li>了解 HGH HBV/HCV 門診的運作方式 (TMM、HGH HBV/HCV 門診負責人 / 2024年7月)</li>
<li>審查<strong>醫療團2024預算</strong>，看是否可能重新分配資金以支持HBV/HCV篩檢和疫苗接種。</li>
<li>為 HGH 醫護人員進行 HBV/HCV 篩檢和 HBV 疫苗接種
<ol type="a">
<li>制定篩檢和接種計劃 (TMM、HGH 人力資源部 / 2024年8月)</li>
<li>執行篩檢和接種 (HGH 醫療團隊、TMM / 2024年9月1日至2024年11月30日)</li>
</ol></li>
<li>制定 HBV 帶原者定期追蹤和治療方案 (TMM + SAHA、HGH HBV 門診負責人 / 2024年10月)</li>
<li>開發索馬利蘭語健康教育手冊
<ol type="a">
<li>內容撰寫 (TMM 、萬芳醫院肝炎專家 / 2024年11月)</li>
<li>翻譯和設計 (當地翻譯人員、設計師 / 2024年12月)</li>
<li>印刷和發放 (TMM、HGH 行政部門 / 2024年12月)</li>
</ol></li>
<li>制定醫護人員 HBV 和 HCV 管理培訓課程
<ol type="a">
<li>課程設計 (萬芳醫院肝炎專家、SAHA Dr.&nbsp;Max, HGH Dr.&nbsp;Ahmed / 2024年9月)</li>
<li>培訓執行 (萬芳醫院肝炎專家、HGH 醫護人員 / 2024年10月1日至2024年12月31日)</li>
</ol></li>
<li>協調 HBV 疫苗和 HCV 治療藥物的採購和供應 (TMM、MoHD national cold chain / 2024年10月1日至2024年12月31日持續進行)</li>
<li>建立 HBV 和 HCV 監測和評估框架 (TMM、MoHD IDSR/ 2024年11月)</li>
<li>定期與 WHO、SAHA、MoHD、HGH 和其他相關者進行策略協調會議 (TMM, Dr.&nbsp;Deq, Dr.&nbsp;Max, Mr.&nbsp;Mahdi Dahir Bahdoon. / 每季一次，從2024年9月開始)</li>
</ul></li>
</ul>
<div style="page-break-after: always;"></div>

<!-- 被動低調

C. 台澳兩國在索馬利蘭的醫療合作：
  
#### 因應現代化開刀房(4 operating theatre rooms) 建設、籌備開刀房內醫療儀器、以及人員訓練。

哈爾格薩總醫院正與澳洲ADFA基金會合作，著手規劃興建四間現代化骨科手術室，預計六個月完成房舍建築。根據ADFA理事長Dr. Graham提供的醫療設備清單(如下)，

- 新建OT所需設備(及現況)如下:

  - 骨科手術床 OR tables for orthopaedics：2張，具透光面板，1張需配備牽引裝置 (traction fittings)、側向支架 (side supports and brackets)
  - 一般手術床 regular OR tables：2張
  - 關節鏡膝部支架 knee brace for arthroscopy：1組
  - 關節鏡塔 arthroscopy towers：2座，各配備2組攝影機 (cameras)、內視鏡 (scopes)、光源 (light sources)；關節刨刀 (模組 shaver modules + 電動手機 hand pieces) 2套
    - **現有設備**：2座關節鏡塔、2組攝影機、4支內視鏡、2組光源 (澳洲ADFA 2022年捐贈)；1台Stryker刨刀 (臺灣2023年捐贈)
    - **尚缺** 2 cameras, 1 關節刨刀 (shaver)

  - 手術無影燈 overhead lights：4組，或2組手術無影燈搭配2組移動式照明燈
  - 麻醉機 anaesthetic machines：4台，廠牌型號需相同(建議為全新品)，以利人員訓練與維護
  - 電燒機 diathermy machines：2台，含1台單極 (mono polar) 式，供神經外科使用
  - 抽吸機 suction machines：4台
  - 止血帶壓力機 tourniquet machines：2台，含止血帶10條
  - 影像增強器暨C臂X光機 image intensifier with C-arm x-ray machine：1台(由現有手術室移撥，**臺灣2023年捐贈**)
  - X光片閱片機 XRay viewing boxes：2台
  - 資訊設備 screens and computers for IT purpose
  - 高壓蒸氣滅菌器 autoclaves：2台
  - 恢復室之監視器 monitors for recovery room：8台
  - 病床 beds：8張；急救藥車 trolleys for transport：4台 (澳洲ADFA提供)
  - 儲藏室層架與工作檯 shelving, bench tops in storage area
  - 給皂機 soap dispensers：2台 for scrubbing



- 經查，臺灣GMISS衛福部二手醫材平台可提供下列器材，且均能正常使用：

  - 手術顯微鏡
  - 高壓滅菌鍋
  - 紫外線消毒燈
  - 防X光屏風
  - 手術推床(病床)
  - 急救藥車
  - 輸血加溫器

- 以上設備需由哈爾格薩總醫院向臺灣GMISS正式提出申請，醫療團**2025年度**的經費可協助支付運送成本。

- **Action points**(who/when): 

  1. 承代表處羅大使指示，懇請萬芳醫院惠予勘估，是否有符合需求的二手設備，得以撥借或捐贈，以共襄盛舉: 查北醫旗下醫院，暫無二手設備可提供。
  
  2. 2024/06/11 承代表處三等祕書翁祕書，轉達羅大使的指示，**待開刀房改建定案，後請優先自醫療團本年度(2024)設備款中提列，上述醫療設備援贈新開刀房使用(預計六個月完成改建)，屆時並建議「集中火力，要有社群及當地媒體露出」**。(Taiwan Medical Mission / after renovation plan finalization)
  
  3. 建議詳細規劃設備來源與運費問題，並由萬芳醫院與外交部協調2025年編列設備經費。(Taiwan Medical Mission / after renovation plan finalization)
  
    - 聚焦提供手術室醫療設備：
    - 符合我方專長，尤其可以避免涉及土木建築等複雜情況。
    - 提供臺灣醫療科技，以及儀器訓練，展現醫療實力，並增加二手平臺(GMISS)醫療設備的使用率。
    - 提供設備使用和維護培訓課程，以確保永續發展。

  4. TMM 與 ADFA 明確界定合作範疇、相輔相成：

    - ADFA主要負責建設和整體項目管理，臺灣提供的醫療設備可與之相輔相成，避免重疊。
    - 與ADFA密切協調，確保我方設備符合其建設規劃和規格（如手術台、牽引裝置、電刀機和抽吸機等）。
    - 為確保臺灣的contribution得到適當紀錄，建議醫療團與ADFA另行簽訂協議MoU (Dr Graham 將於八月份來訪 HGH)。
    - 於手術室建設完成階段，再與衛生部、哈爾格薩總醫院討論認可Taiwan contribution的方式(集中火力，要有社群及當地媒體露出)。

-->
<!-- hold this time
B. 口腔癌

- 與HGH頭頸外科團隊合作,利用Velscope藍光儀器篩檢口腔黏膜病變  
- 背景:索馬利蘭民眾嚼食khat葉、菸草等致癌物非常盛行,為食道癌、口腔癌的重要致癌因素  
- 計畫內容:
  - 攜帶Velscope儀器於門診、偏鄉義診,及早發現口腔癌前病變,轉介確診病人至HGH頭頸外科（耳鼻喉、口腔外科）就醫；
  - 翻譯臺灣健康署口腔癌衛教手冊，推行 somali 與衛教宣導
- 目前進度:萬芳醫院贊助Velscope設備;義診團隊組訓中  
- 瓶頸:偏鄉地區醫療資源匱乏,病人就醫意願低; 嚼食khat葉十分普及

- **Action points**:

  1. 訓練頭頸外科醫事人員，VelScope 儀器使用與門診、義診。

  2. 考量針對口腔癌(黏膜病變)進行研究，調查Khat是否與病變之風險有關，日後再進一步延伸至食道癌(十大癌症排名第一)











Appendix

## Hargeisa Group Hospital (HGH) Intensive Care Unit (ICU) Survey (2024/05/26)

### Bed Capacity and Patient Distribution
- Adult ICU:
  - Total bed capacity: 14 beds (7 for male patients and 7 for female patients)
  - Most medical conditions treated: Cerebrovascular accidents (CVA), pneumonia, acute myocardial infarction (AMI), and major trauma
  - Elective post-operative patients are admitted sometimes (rare major surgery)
- Pediatric ICU: 5 bed capacity
- Neonatal ICU

### Medical Staff of Adult ICU
- Dr. Jacfar is the director of the ICU at HGH
- 8 general practitioner (GP) doctors and 3 internist specialist doctors (including director, and Dr. Saed Ahmed) work in the ICU
- No in-charge physician system; all 8 GP doctors collectively care for the 14 patients
- Medical students rotate through the ICU


### Nursing Staff
- Total number of nurses: 16
  - Shift A: 6 nurses
  - Shift B: 4 nurses
  - Shift C: 6 nurses
- Responsibilities: Vital signs monitoring every shift, nursing documentation every shift, and execution of medical orders
- All 16 nurses collectively care for the 14 patients, with no primary care nursing system in place

### Respiratory Therapist
- One respiratory therapist (RT) is available, working fixed hours during Shift A (Saturday to Thursday) and off on Fridays
- Currently, there are no intubated patients, and the RT performs regular nursing duties
- The RT is a Somalilander who received 10 months of training in the Philippines


### Equipment and Supplies
- Oxygen supply: Cylinders, with dedicated personnel for transportation, supplied by the HGH oxygen concentrator
- Mechanical ventilators: 3 Dräger ventilators (Dräger Evital XL), only one is operational but has not been used yet (tubing x 1 set, water wash re-usable))
(1 or 2 Mindray SV300 is in Emergency department)
- Portable ventilator: (availability uncertain)
- BiPAP (Bilevel ST CPAP): 1 unit (Yuwell YH-830; available; tubing x 1 set, water wash re-usable)
- CPAP: 1 unit (ResMed R370-4117; available but not yet used)
- Suction unit: 1 unit
- Vital signs monitors: 11 monitors (ECG electrodes are lacking, and monitors are used only by orders)
- IV micro-pumps: 6 units
- DC shock (defibrillator): 1 unit (functionality questionable)
- Ultrasound: 1 unit, plus several handheld ultrasound devices (Android tablets) donated and taught by SAHA Dr. Max
- Arterial blood gas (ABG) machine: 1 unit (currently out of reagents)
- Glucometers: 4 units









-->
<!--
###############################
(before 2024/05/10 discussion)
## Taiwan Medical Mission
Collaborative Synergy: The Power of TMM and HGH's Daily Partnership

攜手共創：駐索馬利蘭醫療團與哈格薩總醫院的夥伴關係

來自臺灣的長駐醫療團，醫護人員與哈格薩總醫院的醫療團隊，每日並肩工作能產生非常大的價值與力量。在第一線的緊密合作，是索馬利蘭永續醫療發展的基石。透過共同努力，醫療團隊能深入了解駐地特有的挑戰、因地因時制宜，發現需求和改進的機會。

透過紮根基層的參與，醫療團能夠發現關鍵問題，與本地醫護專家討論，然後創新設計出對應的方案。我們相信，最具影響力的計畫，是由深入醫院日常運作的專業人員，去發掘需求而產生的。這種模式能確保技術上合理，更能符合哈格薩總醫院的優先順序和發展方向。醫療團以專業的方式來發展計畫，結合兩地專家的專長，以實現醫療照護的提升。

## Public health and medical services (common diseases with double burden)

1. The Laparoscopic Training Initiative for General Surgery Department
  - Project: Empowering Surgeons, Transforming Lives: 
  - Led by TMM staff Dr. Andrew Wang, and HGH Dr. Afnan
  - Background: Hargeisa Group Hospital的一般外科醫師皆有豐富的開刀經驗，然受限於醫療資源的缺乏，Somaliland只有在私立醫院才有腹腔鏡手術，公立醫院則無。腹腔鏡手術已經是外科開刀的基本技能，舉凡任何的外科手術，如外傷手術、良性疾病的手術、惡性癌症的手術皆可以應用。HGH的醫師都有在外國接受過腹腔鏡手術的訓練，數位醫師甚至在私立醫院執行腹腔鏡手術。公立醫院若能配備腹腔鏡設備，手術的費用較廉宜，一般民眾也能付擔，有助於顯著提升一般外科的醫療水準。
  - Required equipment: **Laparoscopic surgical instruments** and training models; 借用萬芳醫院的腹腔鏡模擬器械，在王醫師任期內，可以讓每位HGH一般外科醫師均熟悉腹腔鏡的操作。進一步若能編列預算，2024年採購完成腹腔鏡器械，則這項醫療服務將能在HGH生根壯大。

2. Dengue Fever Management and ICU Support:
  - Project: Strengthening Dengue Patient Care and Outcomes
  - Required supplies: **Arterial Blood Gas (ABG) reagent** materials for severe dengue cases in ICU
   
3. Osteoporosis
  - 骨質健康-「TOM 骨質疏鬆」篩檢與預防保健計劃
  - TOM: Taiwan Osteoporosis Master (from femural x-ray to T-score)
  
4. 三大癌症防治計劃(肝癌、子宮頸癌、乳癌)

5. Non-communicable diseases (NCD) 防治計劃

## Outreach

篩檢同步舉辦NCD義診活動(四次)，免費提供醫療服務藥物與諮詢

1. Breast Cancer and Cervical Cancer Screening (子宮頸及乳癌篩檢):
  - Project: Comprehensive Women's Cancer Screening Program
  - Led by HGH Dr. Fatima, TMM staff Dr. Andrew Wang (General Surgeon) and Dr. Huang (OBGYN)
  - CCCP: comprehensive cancer control plans
    - HPV DNA test
    - Pap stain and pathology training: Dr. Chen and Dr. Omar
    - HPV vaccination for school girls (age 9-13)
  - Required equipment: Ultrasound machine and **probes**, **HPV vaccine**
   
2. Osteoporosis
  - HGH orthopedic and Burco General Hospital (BGH)

3. HBV screening and vaccination for HGH staff
  - 與WHO合作
  - 哈格爾薩總醫院 (HGH) **HBV clinic** (since 2024/05)    
  - HGH 約500-700名醫護人員: HBV篩檢和疫苗接種（每人三劑），建立示範效應。隨後逐步擴大至哈格爾薩大學 (University of Hargeisa) 的醫學生和護理系學生
  - 定期追蹤HBV帶原者的肝臟健康
  - 衛生教育：製作索馬利蘭語的宣傳手冊 (Booklet)，向民眾宣導健康飲食、不吸菸、不嚼食khat葉與菸草等，有效預防肝臟發炎
  - Required equipment: **HBV vaccine**


4. Outbound outreach
  - at Naasahablood site B (難民村)
  - triage: 分流(婦兒,男)
  - consultation, medicine, T-score screening
  - health education


## Visiting Scholarships for Training in Taiwan


  - Project: Capacity Building for Somaliland Medical Personnel
  - Collaborators: Taipei Municipal Wanfang Hospital (TMWH), Taiwan Medical Mission (TMM), and Hargeisa Group Hospital (HGH)
  - Initiatives:
    a. Provide "Visiting Scholar Scholarships" for 13 to 15 Somaliland medical personnel to receive training in Taiwan for up to three months
    b. Conduct selection process jointly by Taiwan Medical Mission and HGH Director's Office
    c. Invite selected personnel to participate in **TMM's 2024 public health programs**
  - Required support:
    a. TMM: Scholarship funding for 13 to 15 medical personnel (3 batches of 5)
    b. Coordination with TMWH for training arrangements
    c. Collaboration with HGH for personnel selection and public health program participation
    d. **MoU** between HGH and TMWH
    e. 13 scholarship candidates:
      - Batch 1
        - Dr. Abdirahman Hohamed Osman (**Hospital Director**)
        - Dr. Khadar Good Nur (Infection Prevention Centre Director)
        - Dr. Mohamed Hassan Nur (Resident, Orthopedic)
        - Dr. Hassan Mohamed Nur (Resident, Orthopedic)
      - Batch 2
        - Dr. Saed Mohamed Osman (Resident, Orthopedic)
        - Dr. Abdulrahman Adoosh Abdulaahi (Resident, Orthopedic)
        - Dr. Adnan Sayid Abdo (General Surgery) => **laparoscopic training**
        - Dr. Mustafe Ahmed Yusuf (Neurosurgery) => spine surgery
        - Dr. Idris Hassan Dahir (Cardiologist)
      - Batch 3
        - Dr. Abdihamid Mohamed Ali (Neurosurgery) => cranial surgery
        - Mr. Mustafe (Technician, Pathology)
        - Mr. Ahmed (Nurse, OT director)
        - Dr. Omer Mohamed Bihi (Pathology)

## Medical campaign
  - TMM staff (長駐醫療) by demand
    - orthopedic
    - general surgery
    - OBGYN
    - pediatric
    - emergency and intensive care
  - Medical campaign (主題醫療) by HGH medical need
    - Orthopedic:
      - Arthroscopic knee surgery (meniscus repair, ACL reconstruction)
      - Arthroscopic shoulder surgery (rotator cuff repair, labral repair)
      - Spine surgery (laminectomy, discectomy, spinal fusion)
      - Fracture fixation (open reduction and internal fixation)
      - Required equipment: **arthroscopic instruments**
  
    - General Surgery:
      - Laparoscopic cholecystectomy (gallbladder removal)
      - Laparoscopic appendectomy
      - Laparoscopic hernia repair (inguinal, umbilical, incisional)
      - Thyroidectomy
      - Required equipment: **laparoscopic instruments and video set**

    - Neurosurgery (neurosurgery and maxillofacial department):
      - Craniotomy for brain tumor resection
      - Ventriculoperitoneal shunt placement
      - Spine surgery (laminectomy, discectomy, spinal fusion)
      - Cranioplasty for traumatic skull defects
      - Required equipment: **craniotomy instruments and drill set**

    - Chest Medicine
      - TB Hospital
      - NCD: asthma, chronic obstructive pulmonary disease (COPD)
      - Bronchoscopy for diagnostic and therapeutic purposes
      - Required equipment: **bronchoscope instruments and video set**

  - 門診候診區設置**電視牆**，長期播放衛教宣導資料(一般外科、胸腔內科、骨科、神外、婦產科)





## Telemedicine and medical education

- HGH骨科專科醫師訓練計畫於2023/01/20正式開始
- 2023/10主題醫療骨科專家郭宜潔來訪
- 2024 預計安排四名骨科住院醫師，赴台接受三個月短期訓練
  - Dr. 郭宜潔建議: 請事業發展部先安排一個內部會議，擬定訓練計劃。再和HGH的醫師們會議討論、公告訓練計劃
- 2024 July 骨科專家將再度來訪HGH，指導進階骨折手術、脊椎手術、關節鏡等
- 每季一次進行個案討論 teleconference (一般外科、胸腔內科、骨科、神外、婦產科，內臟內科、病理科、感控室)


## TMM request

- 編列預算購買團車

- 基於衛生部提供的 Nissan NP300 交通車，醫療團每一趟出車均需要司機、SPU 同時出勤，也就是說僅剩下乘客座位三名(擁擠)
  1) 請求衛生部，替換大型車輛(Land Cruiser 八人座以上)
  2) 目前上班、下班，暫時均需要分為兩趟、甚至三趟行車。

## TMM 行政

- 基於衛生部提供的 Nissan NP300 交通車，醫療團每一趟出車均需要司機，乘客座位三、四名，而計劃推展中，常常須要二組人馬出動(不同目的地)，加上因應八月份徐醫師到任，
  1) 上班、下班，暫時均需要分為兩趟、甚至三趟行車。
  2) 請示預算(旅運費)，以支付約**每個月USD1,800的租車費用(司機、車、diesel)**

-->


</section>
</section>
</section>

</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const isCodeAnnotation = (el) => {
    for (const clz of el.classList) {
      if (clz.startsWith('code-annotation-')) {                     
        return true;
      }
    }
    return false;
  }
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    text: function(trigger) {
      const codeEl = trigger.previousElementSibling.cloneNode(true);
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "已复制");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "已复制");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
      let selectedAnnoteEl;
      const selectorForAnnotation = ( cell, annotation) => {
        let cellAttr = 'data-code-cell="' + cell + '"';
        let lineAttr = 'data-code-annotation="' +  annotation + '"';
        const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
        return selector;
      }
      const selectCodeLines = (annoteEl) => {
        const doc = window.document;
        const targetCell = annoteEl.getAttribute("data-target-cell");
        const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
        const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
        const lines = annoteSpan.getAttribute("data-code-lines").split(",");
        const lineIds = lines.map((line) => {
          return targetCell + "-" + line;
        })
        let top = null;
        let height = null;
        let parent = null;
        if (lineIds.length > 0) {
            //compute the position of the single el (top and bottom and make a div)
            const el = window.document.getElementById(lineIds[0]);
            top = el.offsetTop;
            height = el.offsetHeight;
            parent = el.parentElement.parentElement;
          if (lineIds.length > 1) {
            const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
            const bottom = lastEl.offsetTop + lastEl.offsetHeight;
            height = bottom - top;
          }
          if (top !== null && height !== null && parent !== null) {
            // cook up a div (if necessary) and position it 
            let div = window.document.getElementById("code-annotation-line-highlight");
            if (div === null) {
              div = window.document.createElement("div");
              div.setAttribute("id", "code-annotation-line-highlight");
              div.style.position = 'absolute';
              parent.appendChild(div);
            }
            div.style.top = top - 2 + "px";
            div.style.height = height + 4 + "px";
            let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
            if (gutterDiv === null) {
              gutterDiv = window.document.createElement("div");
              gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
              gutterDiv.style.position = 'absolute';
              const codeCell = window.document.getElementById(targetCell);
              const gutter = codeCell.querySelector('.code-annotation-gutter');
              gutter.appendChild(gutterDiv);
            }
            gutterDiv.style.top = top - 2 + "px";
            gutterDiv.style.height = height + 4 + "px";
          }
          selectedAnnoteEl = annoteEl;
        }
      };
      const unselectCodeLines = () => {
        const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
        elementsIds.forEach((elId) => {
          const div = window.document.getElementById(elId);
          if (div) {
            div.remove();
          }
        });
        selectedAnnoteEl = undefined;
      };
      // Attach click handler to the DT
      const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
      for (const annoteDlNode of annoteDls) {
        annoteDlNode.addEventListener('click', (event) => {
          const clickedEl = event.target;
          if (clickedEl !== selectedAnnoteEl) {
            unselectCodeLines();
            const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
            if (activeEl) {
              activeEl.classList.remove('code-annotation-active');
            }
            selectCodeLines(clickedEl);
            clickedEl.classList.add('code-annotation-active');
          } else {
            // Unselect the line
            unselectCodeLines();
            clickedEl.classList.remove('code-annotation-active');
          }
        });
      }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
</div> <!-- /content -->



</body></html>